Szela Mary T — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Szela Mary T has filed 6 SEC Form 4 filings across 3 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $377K. Lifetime open-market sales: $79K.

Profile

Mary T. Szela is an accomplished executive known for her roles as CEO and President of TriSalus Life Sciences, Inc. and as a director at Absci Corp. She has significant experience in the biotechnology sector, focusing on drug delivery technology and immune-oncology therapeutics.

Board memberships

• TriSalus Life Sciences, Inc.
• Absci Corp

Awards & honors

• Leadership in drug delivery technology
• Development of immune-oncology therapeutics
• Experience in executive roles in biotechnology

Recent Transactions

Companies — Last 90 Days

• Absci Corp (ABSI) — 3 filings, last 2026-07-06
• TriSalus Life Sciences, Inc. (TLSI) — 2 filings, last 2026-07-01
• Kura Oncology, Inc. (KURA) — 1 filings, last 2026-06-04

Frequently Asked Questions

Who is Szela Mary T?

Mary T. Szela is an accomplished executive known for her roles as CEO and President of TriSalus Life Sciences, Inc. and as a director at Absci Corp. She has significant experience in the biotechnology sector, focusing on drug delivery technology and immune-oncology therapeutics.…

How many SEC Form 4 filings has Szela Mary T submitted recently?

6 primary Form 4 filings in the last 90 days, covering 3 companies.

Has Szela Mary T been buying or selling stock?

Recorded transactions: 3 open-market purchases ($377K) and 2 open-market sales ($79K) across all tracked filings.

Where can I see all of Szela Mary T's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week